1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Monoclonal Antibody Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Cancer 1.2.3 Autoimmune Diseases 1.2.4 Exogenous Infection 1.2.5 Hematological Diseases 1.3 Market by Application 1.3.1 Global Monoclonal Antibody Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Monoclonal Antibody Treatment Market Perspective (2016-2027) 2.2 Monoclonal Antibody Treatment Growth Trends by Regions 2.2.1 Monoclonal Antibody Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Monoclonal Antibody Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Monoclonal Antibody Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Monoclonal Antibody Treatment Industry Dynamic 2.3.1 Monoclonal Antibody Treatment Market Trends 2.3.2 Monoclonal Antibody Treatment Market Drivers 2.3.3 Monoclonal Antibody Treatment Market Challenges 2.3.4 Monoclonal Antibody Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Monoclonal Antibody Treatment Players by Revenue 3.1.1 Global Top Monoclonal Antibody Treatment Players by Revenue (2016-2021) 3.1.2 Global Monoclonal Antibody Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Monoclonal Antibody Treatment Revenue 3.4 Global Monoclonal Antibody Treatment Market Concentration Ratio 3.4.1 Global Monoclonal Antibody Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Treatment Revenue in 2020 3.5 Monoclonal Antibody Treatment Key Players Head office and Area Served 3.6 Key Players Monoclonal Antibody Treatment Product Solution and Service 3.7 Date of Enter into Monoclonal Antibody Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Monoclonal Antibody Treatment Breakdown Data by Type 4.1 Global Monoclonal Antibody Treatment Historic Market Size by Type (2016-2021) 4.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2022-2027) 5 Monoclonal Antibody Treatment Breakdown Data by Application 5.1 Global Monoclonal Antibody Treatment Historic Market Size by Application (2016-2021) 5.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Monoclonal Antibody Treatment Market Size (2016-2027) 6.2 North America Monoclonal Antibody Treatment Market Size by Type 6.2.1 North America Monoclonal Antibody Treatment Market Size by Type (2016-2021) 6.2.2 North America Monoclonal Antibody Treatment Market Size by Type (2022-2027) 6.2.3 North America Monoclonal Antibody Treatment Market Size by Type (2016-2027) 6.3 North America Monoclonal Antibody Treatment Market Size by Application 6.3.1 North America Monoclonal Antibody Treatment Market Size by Application (2016-2021) 6.3.2 North America Monoclonal Antibody Treatment Market Size by Application (2022-2027) 6.3.3 North America Monoclonal Antibody Treatment Market Size by Application (2016-2027) 6.4 North America Monoclonal Antibody Treatment Market Size by Country 6.4.1 North America Monoclonal Antibody Treatment Market Size by Country (2016-2021) 6.4.2 North America Monoclonal Antibody Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Monoclonal Antibody Treatment Market Size (2016-2027) 7.2 Europe Monoclonal Antibody Treatment Market Size by Type 7.2.1 Europe Monoclonal Antibody Treatment Market Size by Type (2016-2021) 7.2.2 Europe Monoclonal Antibody Treatment Market Size by Type (2022-2027) 7.2.3 Europe Monoclonal Antibody Treatment Market Size by Type (2016-2027) 7.3 Europe Monoclonal Antibody Treatment Market Size by Application 7.3.1 Europe Monoclonal Antibody Treatment Market Size by Application (2016-2021) 7.3.2 Europe Monoclonal Antibody Treatment Market Size by Application (2022-2027) 7.3.3 Europe Monoclonal Antibody Treatment Market Size by Application (2016-2027) 7.4 Europe Monoclonal Antibody Treatment Market Size by Country 7.4.1 Europe Monoclonal Antibody Treatment Market Size by Country (2016-2021) 7.4.2 Europe Monoclonal Antibody Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Monoclonal Antibody Treatment Market Size (2016-2027) 8.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type 8.2.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application 8.3.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region 8.4.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Monoclonal Antibody Treatment Market Size (2016-2027) 9.2 Latin America Monoclonal Antibody Treatment Market Size by Type 9.2.1 Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Monoclonal Antibody Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2027) 9.3 Latin America Monoclonal Antibody Treatment Market Size by Application 9.3.1 Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Monoclonal Antibody Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2027) 9.4 Latin America Monoclonal Antibody Treatment Market Size by Country 9.4.1 Latin America Monoclonal Antibody Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Monoclonal Antibody Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Monoclonal Antibody Treatment Market Size (2016-2027) 10.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type 10.2.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application 10.3.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country 10.4.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Monoclonal Antibody Treatment Introduction 11.1.4 Pfizer Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Bayer 11.2.1 Bayer Company Details 11.2.2 Bayer Business Overview 11.2.3 Bayer Monoclonal Antibody Treatment Introduction 11.2.4 Bayer Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.2.5 Bayer Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Monoclonal Antibody Treatment Introduction 11.3.4 Sanofi Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.3.5 Sanofi Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Monoclonal Antibody Treatment Introduction 11.4.4 Merck Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.4.5 Merck Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Details 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Introduction 11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.5.5 GlaxoSmithKline Recent Development 11.6 Roche 11.6.1 Roche Company Details 11.6.2 Roche Business Overview 11.6.3 Roche Monoclonal Antibody Treatment Introduction 11.6.4 Roche Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.6.5 Roche Recent Development 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview 11.7.3 Novartis Monoclonal Antibody Treatment Introduction 11.7.4 Novartis Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.7.5 Novartis Recent Development 11.8 AbbVie 11.8.1 AbbVie Company Details 11.8.2 AbbVie Business Overview 11.8.3 AbbVie Monoclonal Antibody Treatment Introduction 11.8.4 AbbVie Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.8.5 AbbVie Recent Development 11.9 Shanghai Junshi Biosciences Co.,Ltd 11.9.1 Shanghai Junshi Biosciences Co.,Ltd Company Details 11.9.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview 11.9.3 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Introduction 11.9.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.9.5 Shanghai Junshi Biosciences Co.,Ltd Recent Development 11.10 Innovent Biologics 11.10.1 Innovent Biologics Company Details 11.10.2 Innovent Biologics Business Overview 11.10.3 Innovent Biologics Monoclonal Antibody Treatment Introduction 11.10.4 Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.10.5 Innovent Biologics Recent Development 11.11 Jiangsu Hengrui Medicine Co.,Ltd. 11.11.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details 11.11.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview 11.11.3 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Introduction 11.11.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.11.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development 11.12 BeiGene, Ltd. 11.12.1 BeiGene, Ltd. Company Details 11.12.2 BeiGene, Ltd. Business Overview 11.12.3 BeiGene, Ltd. Monoclonal Antibody Treatment Introduction 11.12.4 BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.12.5 BeiGene, Ltd. Recent Development 11.13 Grand Pharmaceutical (China) Co., Ltd 11.13.1 Grand Pharmaceutical (China) Co., Ltd Company Details 11.13.2 Grand Pharmaceutical (China) Co., Ltd Business Overview 11.13.3 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Introduction 11.13.4 Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.13.5 Grand Pharmaceutical (China) Co., Ltd Recent Development 11.14 Henlius 11.14.1 Henlius Company Details 11.14.2 Henlius Business Overview 11.14.3 Henlius Monoclonal Antibody Treatment Introduction 11.14.4 Henlius Revenue in Monoclonal Antibody Treatment Business (2016-2021) 11.14.5 Henlius Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Monoclonal Antibody Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cancer Table 3. Key Players of Autoimmune Diseases Table 4. Key Players of Exogenous Infection Table 5. Key Players of Hematological Diseases Table 6. Global Monoclonal Antibody Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Monoclonal Antibody Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Monoclonal Antibody Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Monoclonal Antibody Treatment Market Share by Regions (2016-2021) Table 10. Global Monoclonal Antibody Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Monoclonal Antibody Treatment Market Share by Regions (2022-2027) Table 12. Monoclonal Antibody Treatment Market Trends Table 13. Monoclonal Antibody Treatment Market Drivers Table 14. Monoclonal Antibody Treatment Market Challenges Table 15. Monoclonal Antibody Treatment Market Restraints Table 16. Global Monoclonal Antibody Treatment Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Monoclonal Antibody Treatment Market Share by Players (2016-2021) Table 18. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Treatment as of 2020) Table 19. Ranking of Global Top Monoclonal Antibody Treatment Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Monoclonal Antibody Treatment Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Monoclonal Antibody Treatment Product Solution and Service Table 23. Date of Enter into Monoclonal Antibody Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million) Table 26. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2016-2021) Table 27. Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Monoclonal Antibody Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Monoclonal Antibody Treatment Revenue Market Share by Application (2016-2021) Table 31. Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Monoclonal Antibody Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million) Table 34. North America Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million) Table 36. North America Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million) Table 63. Pfizer Company Details Table 64. Pfizer Business Overview Table 65. Pfizer Monoclonal Antibody Treatment Product Table 66. Pfizer Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 67. Pfizer Recent Development Table 68. Bayer Company Details Table 69. Bayer Business Overview Table 70. Bayer Monoclonal Antibody Treatment Product Table 71. Bayer Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 72. Bayer Recent Development Table 73. Sanofi Company Details Table 74. Sanofi Business Overview Table 75. Sanofi Monoclonal Antibody Treatment Product Table 76. Sanofi Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 77. Sanofi Recent Development Table 78. Merck Company Details Table 79. Merck Business Overview Table 80. Merck Monoclonal Antibody Treatment Product Table 81. Merck Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 82. Merck Recent Development Table 83. GlaxoSmithKline Company Details Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Monoclonal Antibody Treatment Product Table 86. GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 87. GlaxoSmithKline Recent Development Table 88. Roche Company Details Table 89. Roche Business Overview Table 90. Roche Monoclonal Antibody Treatment Product Table 91. Roche Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 92. Roche Recent Development Table 93. Novartis Company Details Table 94. Novartis Business Overview Table 95. Novartis Monoclonal Antibody Treatment Product Table 96. Novartis Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 97. Novartis Recent Development Table 98. AbbVie Company Details Table 99. AbbVie Business Overview Table 100. AbbVie Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 101. AbbVie Recent Development Table 102. Shanghai Junshi Biosciences Co.,Ltd Company Details Table 103. Shanghai Junshi Biosciences Co.,Ltd Business Overview Table 104. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product Table 105. Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 106. Shanghai Junshi Biosciences Co.,Ltd Recent Development Table 107. Innovent Biologics Company Details Table 108. Innovent Biologics Business Overview Table 109. Innovent Biologics Monoclonal Antibody Treatment Product Table 110. Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 111. Innovent Biologics Recent Development Table 112. Jiangsu Hengrui Medicine Co.,Ltd. Company Details Table 113. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview Table 114. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product Table 115. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 116. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development Table 117. BeiGene, Ltd. Company Details Table 118. BeiGene, Ltd. Business Overview Table 119. BeiGene, Ltd. Monoclonal Antibody Treatment Product Table 120. BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 121. BeiGene, Ltd. Recent Development Table 122. Grand Pharmaceutical (China) Co., Ltd Company Details Table 123. Grand Pharmaceutical (China) Co., Ltd Business Overview Table 124. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product Table 125. Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 126. Grand Pharmaceutical (China) Co., Ltd Recent Development Table 127. Henlius Company Details Table 128. Henlius Business Overview Table 129. Henlius Monoclonal Antibody Treatment Product Table 130. Henlius Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million) Table 131. Henlius Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Monoclonal Antibody Treatment Market Share by Type: 2020 VS 2027 Figure 2. Cancer Features Figure 3. Autoimmune Diseases Features Figure 4. Exogenous Infection Features Figure 5. Hematological Diseases Features Figure 6. Global Monoclonal Antibody Treatment Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Others Case Studies Figure 10. Monoclonal Antibody Treatment Report Years Considered Figure 11. Global Monoclonal Antibody Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Monoclonal Antibody Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Monoclonal Antibody Treatment Market Share by Regions: 2020 VS 2027 Figure 14. Global Monoclonal Antibody Treatment Market Share by Regions (2022-2027) Figure 15. Global Monoclonal Antibody Treatment Market Share by Players in 2020 Figure 16. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Treatment as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Antibody Treatment Revenue in 2020 Figure 18. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2016-2021) Figure 19. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2022-2027) Figure 20. North America Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Monoclonal Antibody Treatment Market Share by Type (2016-2027) Figure 22. North America Monoclonal Antibody Treatment Market Share by Application (2016-2027) Figure 23. North America Monoclonal Antibody Treatment Market Share by Country (2016-2027) Figure 24. United States Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Monoclonal Antibody Treatment Market Share by Type (2016-2027) Figure 28. Europe Monoclonal Antibody Treatment Market Share by Application (2016-2027) Figure 29. Europe Monoclonal Antibody Treatment Market Share by Country (2016-2027) Figure 30. Germany Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Monoclonal Antibody Treatment Market Share by Type (2016-2027) Figure 38. Asia-Pacific Monoclonal Antibody Treatment Market Share by Application (2016-2027) Figure 39. Asia-Pacific Monoclonal Antibody Treatment Market Share by Region (2016-2027) Figure 40. China Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Monoclonal Antibody Treatment Market Share by Type (2016-2027) Figure 48. Latin America Monoclonal Antibody Treatment Market Share by Application (2016-2027) Figure 49. Latin America Monoclonal Antibody Treatment Market Share by Country (2016-2027) Figure 50. Mexico Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Monoclonal Antibody Treatment Market Share by Type (2016-2027) Figure 54. Middle East & Africa Monoclonal Antibody Treatment Market Share by Application (2016-2027) Figure 55. Middle East & Africa Monoclonal Antibody Treatment Market Share by Country (2016-2027) Figure 56. Turkey Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Pfizer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 60. Bayer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 61. Sanofi Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 62. Merck Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 63. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 64. Roche Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 66. AbbVie Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 67. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 68. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 69. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 70. BeiGene, Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 71. Grand Pharmaceutical (China) Co., Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 72. Henlius Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Pfizer Bayer Sanofi Merck GlaxoSmithKline Roche Novartis AbbVie Shanghai Junshi Biosciences Co.,Ltd Innovent Biologics Jiangsu Hengrui Medicine Co.,Ltd. BeiGene, Ltd. Grand Pharmaceutical (China) Co., Ltd Henlius